Beta Bionics, Inc.

BBNX Nasdaq CIK: 0001674632

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 11 HUGHES, IRVINE, CA, 92618
Mailing Address 11 HUGHES, IRVINE, CA, 92618
Phone 949-427-7785
Fiscal Year End 1231
EIN 475386878

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
4 Insider stock transaction report March 16, 2026 View on SEC
4 Insider stock transaction report March 16, 2026 View on SEC
4/A Insider transaction amendment March 13, 2026 View on SEC
4/A Insider transaction amendment March 13, 2026 View on SEC
4/A Insider transaction amendment March 13, 2026 View on SEC
4/A Insider transaction amendment March 13, 2026 View on SEC
4/A Insider transaction amendment March 13, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC

Material Events

8-K Legal Issue January 30, 2026
High Impact
  • The FDA Warning Letter does not stop Beta Bionics from selling or distributing its current products.
  • The Warning Letter does not block the planned launch of their new "Mint" product.
View Analysis

Insider Trading

STRONG SELL 5 insiders 11 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.